搜索临床试验以:批准的抗 PD-1 抑制剂
总计37978个结果
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.未知
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Shanghai Cell Therapy Research Institute未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Shanghai Cell Therapy Research Institute未知
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.主动,不招人
-
Buzzard PharmaceuticalsBaylor Research Institute招聘中
-
Beijing YouAn HospitalBeijing Gene Key Life Technology Co., Ltd.招聘中
-
Themis Bioscience GmbHAssign Data Management and Biostatistics GmbH; Optimapharm撤销
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Peking University First HospitalYiZhou International Cancer Hospital未知免疫疗法 | 质子治疗
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou Anjie Biomedical Technology Co., Ltd.完全的
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger HF; Haukeland University... 和其他合作者招聘中
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Shanghai Zhongshan Hospital尚未招聘
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical University主动,不招人
-
Symphogen A/S完全的
-
The First Affiliated Hospital of Zhengzhou University招聘中